StreetInsider.com News Articles

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

Thu, 07 Nov 2024 08:30:00 -0500

Common Shares to Begin Trading on Nasdaq on Tuesday, November 12, 2024

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Nasdaq Stock Market LLC has approved the listing of the Company's common shares on the Nasdaq Global Market ("Nasdaq").

The Company expects to begin trading on the Nasdaq on Tuesday, November 12^th, 2024, under the new symbol "BHST". The company's common shares will trade on the OTCQB until market close on November 11^th,

BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market

Thu, 07 Nov 2024 08:30:00 -0500

Common Shares to Begin Trading on Nasdaq on Tuesday, November 12, 2024

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

Wed, 23 Oct 2024 08:30:00 -0500

Management Guides Fourth Quarter Revenues to Grow to at Least $7.2 Million USD; Reaffirms Goal to Complete Nasdaq Uplisting by Year-End

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today preannounced preliminary financial results for the three months ended September 30, 2024. The Company anticipates record revenue of at least $6.5 million in the third quarter of 2024, which represents a 100% increase from the third quarter of 2023.

The company advises that it is at the

BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results

Wed, 23 Oct 2024 08:30:00 -0500

Management Guides Fourth Quarter Revenues to Grow to at Least $7.2 Million USD; Reaffirms Goal to Complete Nasdaq Uplisting by Year-End

The company advises that it is at the

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

Wed, 16 Oct 2024 08:47:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 16, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that management has been invited to attend the LD Micro Main Event XVII Conference taking place on October 30, 2024.

CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the event, and will host a virtual presentation as follows:

LD Micro Main Event XVII Conference
Date: Wednesday, October 30, 2024
Location: Luxe Sunset Boulevard Hotel - Los Angeles, CA
Time: 3:00 p.m. Eastern

BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024

Wed, 16 Oct 2024 08:47:00 -0500

CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the event, and will host a virtual presentation as follows:

LD Micro Main Event XVII Conference
Date: Wednesday, October 30, 2024
Location: Luxe Sunset Boulevard Hotel - Los Angeles, CA
Time: 3:00 p.m. Eastern

BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board

Fri, 20 Sep 2024 08:30:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), announces the resignation of David Ryan as a director of the Company. Mr. Ryan will remain a key member of the Company's management team, continuing to serve as Vice President of Investor Relations of the Company.

Mr. Ryan resigned as a director of the Company in order for the Company to meet Nasdaq mandates to have a majority of independent directors in connection with its proposed application to list its common shares on the Nasdaq Stock Market.

"On behalf

BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board

Fri, 20 Sep 2024 08:30:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 20, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), announces the resignation of David Ryan as a director of the Company. Mr. Ryan will remain a key member of the Company's management team, continuing to serve as Vice President of Investor Relations of the Company.
Mr. Ryan resigned as a director of the Company in order for the Company to meet Nasdaq mandates to have a majority of independent directors in connection with its proposed application to list its common shares on the Nasdaq Stock Market.
"On behalf

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

Thu, 12 Sep 2024 08:30:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 12, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on September 24-25, 2024.
CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and will host a virtual presentation as follows:
iAccess Alpha Buyside Best Ideas Conference
Date: Tuesday, September 24, 2024
Time: 1:00 p.m. Eastern time
Webcast: https://www.webcaster4.com/Webcast/Page/3064/51220
All interested media and

BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024

Thu, 12 Sep 2024 08:30:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 12, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology process, today announced that it has been invited to present at the iAccess Alpha Buyside Best Ideas Investor Conference on September 24-25, 2024.
CEO Ilan Sobel is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and will host a virtual presentation as follows:
iAccess Alpha Buyside Best Ideas Conference
Date: Tuesday, September 24, 2024
Time: 1:00 p.m. Eastern time
Webcast: https://www.webcaster4.com/Webcast/Page/3064/51220
All interested media and

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

Wed, 04 Sep 2024 08:30:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 4, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26^th Annual Global Investment Conference taking place September 9 - 10, 2024 at the Lotte New York Palace Hotel in New York City.
Ilan Sobel, CEO of BioHarvest Sciences, will conduct 1x1 meetings with institutional investors throughout the conference, and deliver the Company's presentation, which can be streamed live or viewed on-demand by the public at the webcast link

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

Wed, 04 Sep 2024 08:30:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 4, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26^th Annual Global Investment Conference taking place September 9 - 10, 2024 at the Lotte New York Palace Hotel in New York City.
Ilan Sobel, CEO of BioHarvest Sciences, will conduct 1x1 meetings with institutional investors throughout the conference, and deliver the Company's presentation, which can be streamed live or viewed on-demand by the public at the webcast link

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

Wed, 04 Sep 2024 08:30:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 4, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26^th Annual Global Investment Conference taking place September 9 - 10, 2024 at the Lotte New York Palace Hotel in New York City.
Ilan Sobel, CEO of BioHarvest Sciences, will conduct 1x1 meetings with institutional investors throughout the conference, and deliver the Company's presentation, which can be streamed live or viewed on-demand by the public at the webcast link

BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference

Wed, 04 Sep 2024 08:30:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 4, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26^th Annual Global Investment Conference taking place September 9 - 10, 2024 at the Lotte New York Palace Hotel in New York City.
Ilan Sobel, CEO of BioHarvest Sciences, will conduct 1x1 meetings with institutional investors throughout the conference, and deliver the Company's presentation, which can be streamed live or viewed on-demand by the public at the webcast link

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

Thu, 29 Aug 2024 09:22:00 -0500

Q2 2024 Revenue Increased 119% Year-over-Year to Over $6.0 Million, Exceeding Management Guidance
Management Expects Third Quarter 2024 Revenues of at Least $6.5 Million, with a Gross Profit Margin of 52%+
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced its financial and operational results for the second quarter ended June 30, 2024.
Second Quarter & Subsequent 2024 Operational Highlights
All figures stated in this news release are in U.S. dollars unless

BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

Thu, 29 Aug 2024 09:22:00 -0500

Q2 2024 Revenue Increased 119% Year-over-Year to Over $6.0 Million, Exceeding Management Guidance
Management Expects Third Quarter 2024 Revenues of at Least $6.5 Million, with a Gross Profit Margin of 52%+
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 29, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced its financial and operational results for the second quarter ended June 30, 2024.
Second Quarter & Subsequent 2024 Operational Highlights
All figures stated in this news release are in U.S. dollars unless

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside

Wed, 28 Aug 2024 09:56:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that its VINIA® Superfood Coffee and Decaf Coffee, a "functional" coffee product line integrating flagship nutraceutical product VINIA® Red Grape Superfood into a premium coffee in the popular Keurig compatible pod format, has surpassed USD $1.0 million in cumulative sales since its launch in December 2023.

Photo of 30

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside

Wed, 28 Aug 2024 09:56:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that its VINIA® Superfood Coffee and Decaf Coffee, a "functional" coffee product line integrating flagship nutraceutical product VINIA® Red Grape Superfood into a premium coffee in the popular Keurig compatible pod format, has surpassed USD $1.0 million in cumulative sales since its launch in December 2023.

Photo of 30

BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time

Fri, 23 Aug 2024 08:30:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, August 29, 2024.
On the call, CEO Ilan Sobel will discuss commercial progress and new product marketing initiatives, second quarter 2024 financial results, third quarter 2024 forecasts, and provide an update on the company's path to a targeted Nasdaq listing in 2024. A live Question & Answer session will follow the conclusion of the presentation.
To participate,

BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time

Fri, 23 Aug 2024 08:30:00 -0500

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 23, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, August 29, 2024.
On the call, CEO Ilan Sobel will discuss commercial progress and new product marketing initiatives, second quarter 2024 financial results, third quarter 2024 forecasts, and provide an update on the company's path to a targeted Nasdaq listing in 2024. A live Question & Answer session will follow the conclusion of the presentation.
To participate,